mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.04 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.04 |
mRNA |
BRD-K16130065 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.04 |
mRNA |
IC-87114 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.04 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.04 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.04 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.04 |
mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.04 |
mRNA |
azacitidine |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.04 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.04 |